Rocket Pharmaceuticals In... (RCKT)
NASDAQ: RCKT
· Real-Time Price · USD
2.54
-0.05 (-1.93%)
At close: Jun 27, 2025, 2:25 PM
Rocket Pharmaceuticals Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
13
Upside
412.82
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| UBS | Buy | Maintains | 12 5 | 97.24% | Jun 17, 2025 | |
| Canaccord Genuity | Buy | Maintains | 34 11 | 333.93% | Jun 3, 2025 | |
| B of A Securities | Buy | Maintains | 32 9 | 255.03% | May 28, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.